Fanconi anemia: matrix remodeling and oral carcinogenesis
By T.A. Silva, N.C.M. Santana, J.A.A. de Arruda, P.A. Rocha, S. Macari, V.Z. Drumond, W.C.S. Silva, L.M. Malard, J.M. Amenábar, C.C. Torres-Pereira, S. Del Marro, A. Pascual, A. Page, R. Errazquin, C. Lorz, R. Garcia-Escudero, F.C. Ferré, N. Dupré, A. Berdal, B.P.J. Fournier
Originally at journals.sagepub.com
Summary & scoring by The Bell Brief (Dr. Jennifer Bell) using the Drill-Down Protocol (Drill-Down Score) — not the original publisher.
Why it matters for dental
Oral surgeons, periodontists, and oral medicine specialists who treat Fanconi anemia patients face an elevated lifetime risk of oral squamous cell carcinoma; this study maps stromal matrix changes that may drive malignant transformation in this population.
Key points
- Fanconi anemia raises the lifetime incidence of oral potentially malignant disorders and oral squamous cell carcinoma.
- Researchers mapped extracellular matrix remodeling in FA-related oral lesions to clarify stromal drivers of carcinogenesis.
- The study focused on the stromal alterations that remain poorly defined in FA patients who develop oral lesions.
Who should care
Read the original on Journal of Dental Research (JDR)
Full reporting and any paywall content live on journals.sagepub.com. We summarize and score; we do not republish.
Related
- ·Regulatory
Is fluoride still safe for kids? A dentist breaks down what the research actually shows
- ·Research
Inflammasome-related transcriptomic profiles in periodontitis
- ·Research
Clinical efficacy of platelet-rich fibrin therapy during oral surgical interventions
- ·Regulatory
Making Sense of Medicare’s Dental Benefit: Top Five Questions from Learners